Member Info for appletree1

Regarding the risk of losing ISA umbrella for unlisted company shares, that need not be an issue here assuming that the transition is done reasonably efficiently. Most providers, like Hargreaves Lansdowne, can allow several months grace for a planned listing of a demerged company's stock before they would feel obliged to move unlisted shares to a non-ISA account.

The spread has narrowed again and currently buys at 1.418 are below the mid, so my current buys are showing as sells. I don't see this going much lower so I am going to continue adding incrementally.

Equally your existing holding of IRR will lead to the RICCA shares being automatically awarded to you once RICCA readies for trading in a couple of months time. They will initially appear in your stocks account with a place-marker with a specified number of shares pro rata 1 to 8 to the number of IRR sharers you hold. The placeholder will show as NA for value until trading of the new stock commences.

This is progress. The modest 3.5m apportionment to the gold is clearly very supportive to IRR and will surely be seen as a positive by the iis that have held off from investing until the demerger. Also, we are now getting much closer to that inflection point where we should start seeing the stock go up to where it should be - ie much higher than the 18p to 24p range that it has been stuck at lately due to that uncertainty.

The inevitable traders and top-slicing may have dampened the strong rise today but this RNS has given me conviction to add more to my holding rather than take profits. The RNS strengthens both fundamentals and technicals IMHO, strengthening the floor at 40p and strengthening the near term target of 80p for warrants as others have noted too. The future is looking increasingly positive for this stock so I'm adding to my holding incrementally now.

Correcting an error is one thing but repeatedly attacking a share is another. You are just being argumentative for the sake of it and attacking a share that you used to hold but don't hold currently. Quite frankly most of us could repeatedly make negative cases against a range of shares including those that you care about. We don't do that because we respect others investments. Why do you do it?

Sangi, please would you stick to ramping 4D and stop trolling TLSA on Stocktwits.

ADVFN chat will prima facie still continue, though can be toxic at times - or perhaps join the StockTwits in USA - or set up a Twitter group?.

So is the famous 'gap' that gets quoted all the time on these boards by chartists simply just the consequence of the MMs opening a share higher with good news? If so it is hardly surprising that a lot of 'gaps' never get filled.

The PXCLF listing on OTC currently is the pre-existing OTC listing from 2018 that doesn't seem to be directly coupled to the AIM stock and vaguely tracks AIM but is basically independent, I believe. The new ADRs referred to in the August RNS will inherently be coupled to the AIM stock since they securitize blocks of existing AIM shares but they don't seem to have been raised yet and when they are they will be given a different ticker on OTC (according to the August RNS ). The ADRs were planned to begin trading in September but everything on OTC is behind schedule at the moment, so we may have to wait a bit longer.

With Mara's stock up another 10% today to an MCAP of 4.8 Billion, is MARA really worth over 6 times more than ARB currently ?

The live price spread is only 3% despite the book spread of 10%. Some may be deterred by the book spread so it doesn't help with volume (chicken-and-egg) but will narrow when volume arrives. Regarding peers, I suspect that this is just on a lag relative to the other LFT stocks and will likely bounce up shortly. In any event there should be a major rise when positive news comes through, so I have just added a bit more to my holding.

Seems that the profit-taking from the high of 1.9p with Friday's RNS is easing up now and we are starting to form a new higher support level than previously. It may yet dip a bit further but I'm continuing to add to my holding. The stock price seems more likely than not to start to rise again into and from the marketing presentation next week as the stock reaches a wider audience.

Not an expert on US stock-market but It looks as though NASDAQ's procedure is less direct than our RNS system. They have a 10 minute rule that requires each company to fore-warn them at least 10 minutes before any public new release, but the release itself seems to be through media like Bloomberg. NASDAQs website seems to be linked to the news feeds such as Businesswire, so by clicking on 'Press releases' in the news and analysis section of a company's page on NASDAQ you should still get the equivalent of RNS promptly. The Argo Blockchain UK RNSs seem to appear in the Press Releases sub-section on the NASDAQ ARBK page promptly. Possibly nevertheless worth using Bloomberg feeds directly??

Only 17 months ago I was paying 240p for this stock and six months ago 150p. Even an 80p target from here feels like an unambitious target. If AIHL starts to sell in volume and/or the POC attracts major interest and/or the existing bead kits receive EUA and Beckman start making serious sales surely this stock should be able to 5-bag very quickly.

Nothing new to see here except reminding the MMs again and pointing out to anyone new to this board that this stock is prima facie massively oversold/undervalued at under 70p. We are currently well below the 110p NASDAQ IPO placing level and overdue a major recovery. We were at 180p at this time last year before firstly the profit-takers and then the algos crashed and then crushed the stock price. To me it looks like the algos that are controlling this stock price are actually stuck in a rut still unfairly basing their pricing on the prices of the Woodford/Acacia fire-sale days. We are still being held down close to those way oversold levels to this day and are far from reflecting true value.

Another reason to buy the dip now - It Looks like Merck need 4D even more now. If not already mentioned here, note that Merck is reported yesterday in FT and Seeking Alpha as on a deals hunt to compensate for Keytruda getting closer to end of patent life. 4D are potentially in a strong position to save Merck.

I don't think many of us are tricked by the large book spreads but it is hard to keep up with the true direction of the trades when the live mid-price doesn't match the book mid-price.NB. It isn't just large spreads in the order book that confuse the pricing algorithms. It can happen with seemingly narrow book spreads too. Every time the live mid-price moves/sits markedly to one side of the book mid price a false buy/sell attribution happens. On some days it seems that practically all trades are misattributed. This might be because the true price is being deliberately obfuscated by the MMs. No doubt they do use this to hide big buys or sells as definitely seemed to be the case when we were having those large trades on the recent rise to 1.44p. Today ADVFN shows 4 times buy volume to sell volume, but checking live prices shows this to be wrong. The buys and sells are probably finely balanced - hence the share price is pretty stable currently.

So, for clarity, Google shows 27.65 simply because that was the last reported trade, but it is actually just a late reported trade from this morning (as you can now see from the trades page on here) and is not the actual last trade of the day. This situation happens a lot. Google is a cheap substitute for up to date share-price (not 15 minute delayed) for those that don't want to pay for level 2 etc but it wont differentiate buy from sell and it wont help identify when trades are late reported.

I think it is irrelevant whether ABDX repeat their confirmatory message of just now in an RNS, What matters is that we have very good reason to believe that ABDX are close to tech transfer completion at least on the Avacta test and it is highly probable that they are fairly close on Vatic too, given the recent press news. Each of these will be RNSed by ABDX on initial purchase orders but I doubt either would delay much in raising their first bulk purchase orders given their interest as expressed on the press and in the other public comments - so we are really primarily just awaiting completion of TT. That could occur at any time and when it does all those that are out will of course struggle (and fail, like I did on Monday morning) to add to or build any decent holding before the inevitable rocket of the stock price. There is no knowing whether the key first RNS will land this week, next or a bit longer but being out seems like a much bigger risk than staying in. Yes we are speculating here but there is reasonable logic to this (unlike many stocks).